Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ventripoint Diagnostics Ltd (OP: VPTDF )

0.0750 UNCHANGED
Streaming Delayed Price Updated: 3:29 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0750
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0750
Today's Range 0.0750 - 0.0750
52wk Range 0.0570 - 0.2474
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification
Toronto, Ontario - TheNewswire - (October 11, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce that it has submitted its next... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital... 
Via TheNewswire.com

Performance

YTD
-8.54%
-8.54%
1 Month
+17.74%
+17.74%
3 Month
-31.76%
-31.76%
6 Month
-53.12%
-53.12%
1 Year
-68.98%
-68.98%

More News

Read More
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
Via TheNewswire.com
Ventripoint Announces Patent Application for Improved Heart Analysis
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint update on its Financial Status and on Warrant and Option Exercises
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence COVID-19 Intellectual Property
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.